🇯🇵 Direct Oral Anticoagulants in Japan

Direct Oral Anticoagulants (Direct Oral Anticoagulants) regulatory status in Japan.

Marketing authorisation

PMDA

  • Application: Xarelto Partial Change Approval
  • Local brand name: Xarelto Partial Change Approval
  • Status: approved

Read official source →

Direct Oral Anticoagulants in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Direct Oral Anticoagulants approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Direct Oral Anticoagulants in Japan?

University Hospital, Brest is the originator. The local marketing authorisation holder may differ — check the official source linked above.